Fundacion Investigacion Interhospitalaria Cardiovascular
10
2
3
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
10.0%
1 terminated/withdrawn out of 10 trials
75.0%
-11.5% vs industry average
20%
2 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Microvascular Dysfunction in Patients With Long-Covid Syndrome and Angina
Role: lead
Remote Symptom Review in Patients With Implantable Diagnostic Holter
Role: collaborator
Influence of Calcium Pattern on Plaque Modification Achieved With Intracoronary Lithotripsy
Role: lead
Prognostic Value of Ventricular Fibrillation Spectral Analysis in Sudden Cardiac Death
Role: collaborator
Advanced Invasive Diagnosis for Patients With Chronic Coronary Syndromes Undergoing Coronary ANGIOgraphy (AID-ANGIO)
Role: collaborator
Myocardial Ischemia Without Obstructive Coronary Stenoses
Role: collaborator
Paclitaxel Eluting Balloon After Bare Metal Stent Implantation vs. Drug-Eluting Stent in St Elevation Myocardial Infarction
Role: lead
Vessel Injury in Relation With Strut Thickness Assessed by OCT
Role: lead
Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate in STEMI Patients
Role: lead
PRotective Effect on the Coronary Microcirculation of Patients With DIabetes by Clopidogrel or Ticagrelor
Role: lead
All 10 trials loaded